
Rosen Law Firm Urges MoonLake Immunotherapeutics Investors to Act Before December 15 Deadline
Rosen Law Firm, a global investor‑rights firm, is reminding anyone who purchased common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between Ma...
Found 192 articles